Form D · Biotechnology

Azitra Inc

Branford, CT · CIK 0001701478

Offering snapshot reported Oct 12, 2022 · SEC filing

Reported sold
$4.35M
Offering amount: $4.5M
Investors reported
5
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 16, 2022
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 12, 2022Initial$4,350,000No comparison5SEC filing
Jan 19, 2021Initial$1,000,000No comparison1SEC filing
Sep 24, 2020Initial$17,000,159No comparison8SEC filing
Mar 1, 2019Initial$4,699,710No comparison5SEC filing
Apr 26, 2018Initial$2,125,000No comparison5SEC filing
Mar 20, 2017Initial$2,900,010No comparison3SEC filing

Offering details

Securities
Debt, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-461550

Source: Form D, filed Oct 12, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Richard Andrews Director, Executive
Ricahrd Andrews Director, Executive
Lucio Iannone Director
Naveen Krishan Director
Andrew Mcclary Director
Andrew Mc Clary Director
Cain Mc Clary Director
Azim Munivar Director
Stella Robertson Director
Francisco Salva Director, Executive
Daniel Wagner Director
Travis Whitfill Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
21 Business Park Drive, Suite 6
Branford, CT, 06405